Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -50.45%-393.69K | -21.07%-314.49K | 86.24%-29.06K | 61.29%-574.99K | 97.23%-15.4K | 41.37%-261.67K | -2.30%-259.76K | 7.55%-211.23K | -1.49M | -556.75K |
| Net income from continuing operations | 12.67%-441.49K | 40.79%-400.73K | 21.98%-517.04K | 69.75%-3.07M | 70.32%-1.22M | 90.51%-505.57K | -63.76%-676.76K | -134.03%-662.69K | ---10.14M | ---4.11M |
| Depreciation and amortization | 0.74%81.8K | 0.25%81.4K | 0.25%81.4K | 345.59%325.28K | 11.90%81.68K | --81.2K | --81.2K | --81.2K | --73K | --73K |
| Remuneration paid in stock | -75.26%40.25K | -29.91%112.79K | -54.67%120.25K | -14.71%1.32M | -47.50%733.97K | 6.42%162.69K | --160.92K | --265.26K | --1.55M | --1.4M |
| Other non cashItems | ---- | ---- | ---- | -98.57%97.2K | -107.13%-159.79K | ---- | ---- | ---- | --6.78M | --2.24M |
| Change In working capital | ---74.25K | -161.73%-107.95K | 172.70%286.33K | 198.63%745.62K | 454.96%549.66K | --0 | 24.57%174.88K | 181.85%105K | --249.68K | ---154.85K |
| -Change in receivables | --0 | -340.76%-33.6K | 910.69%33.6K | ---- | ---- | --0 | ---7.62K | ---4.14K | ---62.59K | ---- |
| -Change in prepaid assets | ---112.5K | --0 | --0 | ---- | ---- | --0 | --32.44K | ---21.63K | ---- | ---- |
| -Change in payables and accrued expense | ---- | ---- | 93.27%252.73K | ---- | ---- | ---- | --150.06K | --130.77K | --312.27K | ---- |
| -Change in other working capital | -92.60%38.25K | ---- | ---- | ---- | ---- | --517.08K | 6.22%149.11K | 251.02%130.77K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -50.45%-393.69K | -21.07%-314.49K | 86.24%-29.06K | 61.29%-574.99K | 97.23%-15.4K | 41.37%-261.67K | -2.30%-259.76K | 7.55%-211.23K | ---1.49M | ---556.75K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 90.44%-6.24K | -105.92%-16.34K | 15.05%-29.96K | 97.79%-14.11K | 109.25%94.28K | -107.36%-65.19K | 94.35%-7.94K | 90.32%-35.27K | -637.83K | -1.02M |
| Net PPE purchase and sale | 90.44%-6.24K | -105.92%-16.34K | 15.05%-29.96K | 67.08%-209.96K | -32.86%-101.57K | 10.94%-65.19K | 97.62%-7.94K | 77.18%-35.27K | ---637.83K | ---76.45K |
| Net other investing changes | ---- | ---- | ---- | --195.85K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 90.44%-6.24K | -105.92%-16.34K | 15.05%-29.96K | 97.79%-14.11K | 109.25%94.28K | -107.36%-65.19K | 94.35%-7.94K | 90.32%-35.27K | ---637.83K | ---1.02M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 361K | 287.5K | 1,873.33%370K | -96.93%78.04K | -94.31%59.29K | 0 | 0 | -98.13%18.75K | 2.54M | 1.04M |
| Net issuance payments of debt | --0 | ---50K | --25K | -98.42%23.71K | --23.71K | --0 | --0 | --0 | --1.5M | --0 |
| Net common stock issuance | --361K | ---- | ---- | --49.37K | --49.37K | --0 | ---- | ---- | --0 | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | -81.25%18.75K | --0 | --0 | --0 | --18.75K | --100K | --100K |
| Net other financing activities | ---- | ---40K | --345K | -101.46%-13.79K | ---- | ---- | ---- | ---- | --943.71K | --942.38K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --361K | --287.5K | 1,873.33%370K | -96.93%78.04K | -94.31%59.29K | --0 | --0 | -98.13%18.75K | --2.54M | --1.04M |
| Net cash flow | ||||||||||
| Beginning cash position | 289.89%259.79K | 8.88%339.15K | -94.78%28.16K | 354.05%539.22K | -95.72%45.91K | -49.37%66.63K | -40.79%311.47K | 354.05%539.22K | --118.76K | --1.07M |
| Current changes in cash | -87.88%-38.93K | 82.31%-43.36K | 236.55%310.98K | -221.55%-511.06K | 96.67%-17.75K | -102.20%-20.72K | 37.86%-245.11K | -155.92%-227.75K | --420.46K | ---533.22K |
| End cash Position | 381.06%220.86K | 345.73%295.79K | 8.88%339.15K | -94.78%28.16K | -94.78%28.16K | -95.72%45.91K | -49.57%66.36K | -40.79%311.47K | --539.22K | --539.22K |
| Free cash from | -52.83%-399.93K | -23.59%-330.84K | 76.06%-59.02K | 63.03%-784.95K | 81.53%-116.97K | 49.63%-261.67K | 54.44%-267.69K | 35.65%-246.5K | ---2.12M | ---633.2K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.